Cutaneous T-Cell Lymphoma (CTCL) Arising Post Kidney Transplant: A Review of Clinical Variants in the Literature-Reference-Cited by-同舟云学术

Cutaneous T-Cell Lymphoma (CTCL) Arising Post Kidney Transplant: A Review of Clinical Variants in the Literature

Published:2023-12-28 Issue:1 Volume:16 Page:11-21
ISSN:2038-8330
Container-title:Hematology Reports
language:en
Short-container-title:Hematology Reports

Author:

Pilkington Jordan¹,Shalin Sara²,Wong Henry K.²³^ORCID

Affiliation:

1. College of Medicine, University of Arkansas for Medical Sciences: 1, Little Rock, AR 72205, USA

2. Department of Dermatology, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA

3. Central Arkansas Veterans Health System, Little Rock, AR 72205, USA

Abstract

Post-transplant lymphoproliferative disease is a rare disorder with an annual incidence of 0.5% to 3.7%. Development of this disorder carries with it a poor prognosis. In this report, we describe a rare case of post-transplant primary cutaneous T-cell lymphoma (PT-CTCL) mycosis fungoides stage IIB in a patient following kidney transplantation, as well as a review of PT-CTCL reported in the literature. The treatment following diagnosis included bexarotene, cyclosporine, and prednisone. Currently, the patient is free from disease. This information aims to add to the knowledge of the prevalence and management of PT-CTCL.

Publisher

MDPI AG

Subject

Hematology

Link

https://www.mdpi.com/2038-8330/16/1/2/pdf

Reference44 articles.

1. Death after Kidney Transplantation: An Analysis by Era and Time Post-Transplant;Ying;JASN,2020

2. Post-transplant cutaneous T-cell lymphomas;Lok;Crit. Rev. Oncol./Hematol.,2005

3. Singavi, A.K., Harrington, A.M., and Fenske, T.S. (2015). Non-Hodgkin Lymphoma. Cancer Treatment and Research, Springer.

4. Primary cutaneous posttransplant lymphoproliferative disorders in solid organ transplant recipients: A multicenter European case series;Barete;Am. J. Transplant. Off. J. Am. Soc. Transplant. Am. Soc. Transpl. Surg.,2013

5. Oral bexarotene for post-transplant cutaneous T-cell lymphoma;Lewis;Dermatol. Ther.,2017